help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shain, S. A.
Right arrow Articles by Lancaster, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shain, S. A.
Right arrow Articles by Lancaster, C. M.

Endocrinology, Vol 119, 1830-1838, Copyright © 1986 by Endocrine Society


ARTICLES

Aging in the AXC/SSh rat: diminished prostate L-ornithine decarboxylase (ODC) activity reflects diminished prostate ODC protein and transcript content

SA Shain, JJ Schultz and CM Lancaster

Immunotitration of L-ornithine decarboxylase (ODC) activity in ventral prostates of young mature (6-month-old) and aged (26-month-old) AXC/SSh rats established that the relation between enzyme activity and prostate ODC mass content was age invariant, demonstrating that the 4-fold diminution in prostate ODC activity in aged subjects represents decreased ODC protein content. Testosterone treatment of aged rats increased prostate ODC activity 2-fold and did not affect prostate ODC half-life. These latter findings and the preceding observation established that the testosterone-mediated increase in prostate ODC activity in aged individuals reflected increased ODC mass content. The half-life of prostate S-adenosyl-L-methionine decarboxylase, another prominent enzyme of polyamine biosynthesis, also was not altered by testosterone treatment of 26-month-old animals. The age-related diminution and testosterone-mediated increase in ventral prostate ODC activity occurred in concert with comparable quantitative changes in ventral prostate ODC transcript content. Because plasma testosterone content was age invariant between 3 and 18 months, the age span during which much of the reduction in prostate ODC activity occurs, and then declined by 50% at 26 months, our studies suggest that age-related diminutions in prostate ODC activity and transcript content reflect altered prostate sensitivity to androgen rather than response to diminished plasma testosterone content. Our data imply that age-related alterations in androgen regulation of androgen-responsive genes may be characteristic of the prostate during aging.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society